top of page

Lewis Lung LLC1 Syngeneic Model

Rincon Bio offers efficacy studies using the Lewis Lung LLC1 Syngeneic Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Syngeneic
Organ:
Lung
Derivation:
From transplantation of a spontaneous Lewis Lung carcinoma in a C57BL/6 mouse
Mutations:
Unavailable
NCI60:
No
Weeks from stratification to termination (average):
3

Lewis Lung LLC1 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the Lewis Lung LLC1 syngeneic model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

All Xenograft Models

All Syngeneic Models

bottom of page